Torigen Pharmaceuticals, Inc.
PrivateLast Round
Series A
Extension
Nov 16, 2022
Total Funding Raised
$22.31M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Torigen Pharmaceuticals, Inc. operates in Healthcare & Life Sciences and is based in Farmington, Connecticut. Its latest recorded funding round was a Series A Extension round in November 2022.
Torigen Pharmaceuticals, Inc. is a biotechnology company that provides personalized cancer immunotherapies for companion animals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Torigen Pharmaceuticals, Inc. Comparables
Compare Torigen Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CAVU Biotherapies | 88% | |
| ELIAS Animal Health | 85% | |
| FidoCure | 81% |
For institutional investors. Book with your work email.
Torigen Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 16, 2022 | ||||
| Series A | Mar 4, 2021 | ||||
| Series A | Feb 18, 2019 | ||||
| Seed | Aug 21, 2018 | ||||
| Convertible Debt | Oct 20, 2017 | ||||
Convertible Debt | Mar 23, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Torigen Pharmaceuticals, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Series A, Seed, Convertible Debt, Series A Extension |
| Emerald Development Managers | Series A Extension, Series A |
| Advantage Capital | Series A Extension |
| Gaingels | Series A Extension, Series A |
| Werth Family Investment Associates | Series A Extension |
| SoGal Ventures | Series A Extension, Series A |
| Sofia Fund | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 79% MoM.
- Jul 20, 2026
Open roles increased from 0 to 10, representing 45% of headcount.
For institutional investors. Book with your work email.
Torigen Pharmaceuticals, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Torigen Pharmaceuticals, Inc.'s valuation, stock price, and market status.
Is Torigen Pharmaceuticals, Inc. a public or private company?
Torigen Pharmaceuticals, Inc. is a private company.
What is the current stock price of Torigen Pharmaceuticals, Inc.?
Torigen Pharmaceuticals, Inc. is a private company, so its shares have no public market price. Caplight tracks Torigen Pharmaceuticals, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Torigen Pharmaceuticals, Inc. worth (valuation)?
Valuation information for Torigen Pharmaceuticals, Inc. is not publicly available.
Can I buy Torigen Pharmaceuticals, Inc. stock?
Torigen Pharmaceuticals, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Torigen Pharmaceuticals, Inc.'s last funding round?
Torigen Pharmaceuticals, Inc.'s most recent funding round was Series A Extension on November 16, 2022.
Who are the main investors in Torigen Pharmaceuticals, Inc.?
Key investors in Torigen Pharmaceuticals, Inc. include Connecticut Innovations, Werth Family Investment Associates.
Will Torigen Pharmaceuticals, Inc. IPO soon?
No public IPO plans have been announced for Torigen Pharmaceuticals, Inc..
How can I track Torigen Pharmaceuticals, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Torigen Pharmaceuticals, Inc.'s shares on secondary markets.